| Kukatz, Ingo (vierviertel 201504 Managing Partner) |
Managing Director |
vierviertel – Agentur für Kommunikationsdesign GmbH |
Germany |
| Kukuk, Nicole (BIO Deutschland 201609) |
n. a. |
BIO Deutschland e. V. |
Germany |
| Kukutai, Arama (Finistere Ventures 201502 Partner + Co-founder) |
Venture Partner |
Finistere Partners LLC (Finistere Ventures) |
United States (USA) |
| Kulak, Nils A. (PreOmics GmbH 201601– Managing Director + Co-Founder) |
Managing Director |
PreOmics GmbH |
Germany |
| Kulick, Stefan (KSK Diagnostics GmbH 201704 CEO + Co-Founder) |
Managing Director |
KSK Diagnostics GmbH |
Germany |
| Kulkarni, Samarth (Sam) (CRISPR Therapeutics 201712– promoted CEO before CBO) |
Chief Executive Officer (CEO) |
CRISPR Therapeutics (Group) |
Switzerland |
| Kull, Toomas (Cabinet Privé de Conseils 202009) |
Public Relations Manager / Investor Relations Manager |
Cabinet Privé de Conseils S.A. |
Switzerland |
| Kumar, Hemant (Rentschler 201911– VP Process Sciences Rentschler Biopharma Inc before AnaptysBio + Merck) |
n. a. |
Rentschler (Group) |
United States (USA) |
| Kumar, Nilesh (Novo 201701– Partner at Novo Ventures joined 201504 before Merk Serono Ventures) |
Partner (venture partner) |
Novo Group (Group) |
United States (USA) |
| Kumar, Sumeet (Innatera Nanosystems 202011 CEO) |
Chief Executive Officer (CEO) |
Innatera Nanosystems B.V. |
Netherlands |
| Kumar, Yadhu (GATC Biotech 201611 Head of BioIT Development) |
n. a. |
Eurofins (Group) |
Germany |
| Kuner, Michael (Nycomed 200802– Executive VP) |
Legal Manager |
Takeda (Group) |
Switzerland |
| Kungl, Andreas (ProtAffin 201103 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Protaffin Biotechnologie AG |
Austria |
| Kunst, Manuel (Maucher, Börjes & Kollegen 200809 Freiburg) |
n. a. |
Maucher, Börjes & Kollegen Patent- und Rechtsanwaltssozietät (Freiburg) |
Germany |
| Kunz, Andreas (Bruker 201003 Sales Director Bruker Elemental) |
Sales Manager / Marketing Manager |
Bruker (Group) |
Germany |
| Kunze, Peter (Eppendorf Vertrieb Deutschland GmbH 200710) |
n. a. |
Eppendorf (Group) |
Germany |
| Kupas, Verena (MorphoSys 201901 Manager Corporate Communications & IR) |
Public Relations Manager / Investor Relations Manager |
MorphoSys (Group) |
Germany |
| Kurapkat, Gunther (TEMIS 200408 Director BusDev) |
Business Development Manager / Strategy Manager |
Expert System (Group) |
Germany |
| Kurihara, Gon-emon (JEOL 201108 President) |
President/Director/Head Business Group/Unit/Division |
JEOL (Group) |
Japan |
| Kurji, Naheed (Cyclica 201811 CEO) |
Chief Executive Officer (CEO) |
Cyclica Inc. |
Canada |
| Kurz, Allison (Genedata 201004 Marketing & Communication) |
Public Relations Manager / Investor Relations Manager |
Genedata (Group) |
Switzerland |
| Kusser, Wolfgang (Automation Partnership 201102– Sales Manager DE+AT+CH before Invitrogen Germany) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
United Kingdom (GB) |
| Kutter, Susanne (MC Services 201910) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Kutzer, Stephan (Lonza 201302– COO before 200807 Head of Biopharma) |
Chief Operating Officer (COO) |
Lonza (Group) |
Switzerland |
| Kuzmin, Dmitry (Dima) (4BIO Ventures 2019 Managing Partner) |
Managing Partner (investment firm) |
4BIO Ventures (4BIO Capital) (Group) |
United Kingdom (GB) |
| Kvalheim, Gunnar (Univ Oslo 201504 Prof at Dept of Cellular Therapy at Oslo Univ Hospital) |
Professor |
University of Oslo |
Norway |
| Kübler, Olaf |
n. a. |
ETH Zürich (ETHZ) |
Switzerland |
| Kück, Matthias (Biozoon Food Innovations 200902 Managing Director) |
Managing Director |
Biozoon Food Innovations GmbH |
Germany |
| Küenburg, Bernhard (MorphoMed 201709 CEO) |
Chief Executive Officer (CEO) |
MorphoMed GmbH |
Austria |
| Kühlcke, Klaus (BioNTech 201309 Managing Director of Eufets GmbH) |
Managing Director |
BioNTech (Group) |
Germany |
| Kühling, Dirk (Bremen (govt) 200907 Senator für WIrtschaft + Häfen Abteilungsleiter) |
n. a. |
Bremen (govt region) |
Germany |
| Kühling, Guido (EWE 201711 Head of Corporate Development) |
Business Development Manager / Strategy Manager |
EWE (Group) |
Germany |
| Kühn, Klaus (Bayer 200603 CFO) |
Chief Financial Officer (CFO) |
Bayer (Group) |
Germany |
| Kühn, Sabine (Eppendorf AG 200711) |
n. a. |
Eppendorf (Group) |
Germany |
| Kühn, Till (Bruker 201203 Product Manager at Bruker BioSpin for small molecule applications) |
Product Manager (personnel) |
Bruker (Group) |
Germany |
| Kühnel, Stefan (Biopract GmbH 201704 Head of Enzyme + Substrate Analysis) |
Technical Manager |
Biopract GmbH [since 8/12] |
Germany |
| Kühner, Daniel (CeCo Labs 201108– Managing Director + Co-founder) |
Managing Director |
CeCo Labs UG (haftungsbeschränkt) |
Germany |
| Kühner, Markus (Adolf Kühner AG 200905 CEO) |
Chief Executive Officer (CEO) |
Adolf Kühner AG |
Switzerland |
| Kümmerle, Rainer (Bruker 201703 NMR Product Manager at Bruker BioSpin) |
Product Manager (personnel) |
Bruker (Group) |
Germany |
| Künast, Renate |
n. a. |
Germany (govt) |
Germany |
| Künnecke, Kai (EuropaBio 202009 Communciations Officer) |
Public Relations Manager / Investor Relations Manager |
EuropaBio aisbl – the European Association of Bioindustries |
Belgium |
| Küpper, Hans A. (Global Life Science Ventures 199902– Managing Director Munich before Behringwerke) |
Managing Director |
Global Life Science Ventures (Group) |
Germany |
| Küster, Bernhard (Technical Univ Munich 201107 Professor Proteomics + Bioanalytics) |
Professor |
Technical University Munich (TU München, TUM) |
Germany |
| Küsthardt, Ulrich (Evonik 201501– Chief Innovation Officer joined Evonik 1997) |
Chief Technology/Technical Officer (CTO) |
Evonik (Group) |
Germany |
| Kähler, Markus (IP Bewertungs AG 200908) |
n. a. |
IP Bewertungs AG (IPB) |
Germany |
| Källblad, Per (Beactica AB 2006– CEO + Co-founder before Medivir AB) |
Chief Executive Officer (CEO) |
Beactica AB |
Sweden |
| Kärtner, Franz (Helmholtz 201603 Head of Research Group at DESY Hamburg + Co-Founder of Cycle GmbH) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Käsmarker, Melanie (Coral BioNet 201112– Director of Finance at Scil Proteins before Head Controlling + Accounting) |
Chief Financial Officer (CFO) |
UV-Cap (Group) |
Germany |
| Kässens, Werner (Kiel (govt) 201202 Prokurist of KiWi GmbH + Managing Director Wissenschaftszentrum Kiel) |
Managing Director |
Kiel (govt city) |
Germany |
| Kääb, Georg (BioM 201110 Cluster Manager) |
Cluster Manager |
Bavaria (govt region) |
Germany |
| Köckler, Jochen (Deutsche Messe AG 201410 Member of Management Board) |
Board member, executive |
Deutsche Messe AG |
Germany |
| Köglmayr, Hans-Georg (Leonardo Venture 2007) |
n. a. |
Leonardo Venture GmbH & Co. KGaA |
Germany |
| Köhl, Claudia (Köhl et Feling 201310 Partner) |
Public Relations Manager / Investor Relations Manager |
Innovation Industries (NL) |
Germany |
| Köhler, Christoph (Berlin (govt) 201009 BBges Institute of Toxicology) |
Administrative Officer (personnel) |
Berlin (govt region) |
Germany |
| Köhler, Gert (Creathor GmbH 200601 before Technologieholding) |
n. a. |
Creathor Ventures (Group) |
Germany |
| Köhler, Helmut (Olympus 200412 Managing Director of Olympus Diagnostika GmbH) |
Managing Director |
Olympus (Group) |
Germany |
| Köhler, Jörg (Klocke 201411 Managing Director of IDT Biologika (Riems)) |
Managing Director |
Klocke (Group) |
Germany |
| Köhler, Thomas (AJ RoboScreen 200810 Managing Director) |
Managing Director |
Endress+Hauser (Group) |
Germany |
| Köhn, Heinz Gerhard (Eppendorf 2006 Chief Technology + Production Officer joined in 1999) |
n. a. |
Eppendorf (Group) |
Germany |
| Köhne-Volland, Rudolf (Metronomia Clinical Research GmbH 202001 Managing Director) |
Managing Director |
Metronomia Clinical Research GmbH |
Germany |
| Kölpin, Alexander (WestTech Ventures 201602 COO + Partner) |
Chief Operating Officer (COO) |
WestTech Ventures |
|
| König, Anja (Novartis 200910 Novartis Venture Fund) |
Investment Manager |
Novartis (Group) |
Switzerland |
| König-Wildförster, Corinna (Lonza 201211 Marketing Communications + Product PR Lonza Cologne GmbH) |
public relations / investor relations |
Lonza (Group) |
Germany |
| Köppele, Winni (Laborjournal 200509) |
n. a. |
LJ-Verlag Herfort und Sailer |
Germany |
| Köppen, Herbert (Boehringer Ingelheim Pharma GmbH 200302 Head Cheminformatics) |
n. a. |
Boehringer Ingelheim (Group) |
Germany |
| Köpper, Sabine (PKCie 201305 Managing Partner) |
Managing Partner |
PKCie – Prof. Köpper & Cie Management Consultants GbR |
Germany |
| Körner, Kay (Eppendorf 200610 before artus) |
Product Manager (personnel) |
Eppendorf (Group) |
Germany |
| Köster, Hubert (Caprotec 200805–201009 Managing Director + Univ Hamburg + Sequenom founder + CEO) |
Managing Director |
Caprotec Bioanalytics GmbH |
Germany |
| Köster, Miriam (G. Kisker 200512) |
n. a. |
G. Kisker GbR |
Germany |
| Köstlin, Ulrich (Newron 2013– Board Chairman before until 2011 Management Board Member of Bayer Schering Pharma AG) |
Board member, non-executive |
Newron (Group) |
Italy |
| La Thangue, Nick (SynOx Therapeutics 202011 CEO) |
Chief Executive Officer (CEO) |
SynOx Therapeutics Ltd. |
Ireland, Republic of |
| Labinger, Barry (Emergent BioSolutions 201408 EVP + President Biosciences Division) |
President/Director/Head Business Group/Unit/Division |
Emergent BioSolutions (Group) |
United States (USA) |
| Labischinski, Harald (Combinature 200504– CEO before 12y Bayer HealthCare) |
Chief Executive Officer (CEO) |
MerLion (Group) |
Germany |
| Laborde, Nadège (Novasep 201311– President of Industrial Biotech business unit joined Novasep 2000) |
President/Director/Head Business Group/Unit/Division |
Novasep (Group) |
France |
| Labrum, Ron (Fenwal 201207 CEO) |
Chief Executive Officer (CEO) |
Fresenius (Group) |
United States (USA) |
| LaCaze, Robert (Bayer 201702– EVP of new Oncology Strategic Business Unit joined 2015 from BMS) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Lacey, Nora (Cell Marque 201410 CEO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
United States (USA) |
| Lachmann, Ingolf (Endress+Hauser 201501 Head RnD at AJ Roboscreen GmbH) |
Research & Development Manager |
Endress+Hauser (Group) |
Germany |
| Lacza, Zsombor (Lacerta Technologies GmbH 201404 CEO + Founder) |
Chief Executive Officer (CEO) |
OrthoSera (Group) |
Austria |
| Ladd, Mark (Helmholtz 201810 Prof + Head of Medical Physics in Radiology at DKFZ) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Ladd, Susanne (Quantum Analysis 201202 Managing Director) |
Managing Director |
Quantum Analysis GmbH (QA) |
Germany |
| Ladestein, Paul (MyCartis 201409– CEO before Biocartis 201404 Managing Director of business unit Evalution + Luminex) |
Chief Executive Officer (CEO) |
MyCartis |
Switzerland |
| Ladiwala, Shiraz (Thermo Fisher 202003 SVP Strategy + Corporate Development joined 20y+ ago TO RETIRE 3/21) |
Corporate Strategy Manager |
Thermo Fisher (Group) |
United States (USA) |
| Lafeuille, Marc (Bayer 201101 Managing Director of Intendis GmbH) |
Managing Director |
Bayer (Group) |
Germany |
| Laffert, Bernd (CCS Cell Culture Service 200805 Head of Research) |
Research & Development Manager |
Evotec (Group) |
Germany |
| Laggner, Peter (Bruker 201201– Director Nanostructure Solutions at Bruker AXS before Hecus X-Ray Systems GmbH) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
Germany |
| Lahn, Michael (iOnctura 201903– CMO before Incyte + AstraZeneca + Lilly) |
Chief Medical Officer (CMO) |
iOnctura (Group) |
Switzerland |
| Lai, Kevin (Singapore (govt) 201203 Deputy Director Biomedical Sciences at EDB) |
n. a. |
Singapore (govt) |
Singapore |
| Laikind, Paul (ViaCyte 201206– CEO before Gensia + Viagen + Metabasis) |
Chief Executive Officer (CEO) |
ViaCyte (Group) |
United States (USA) |
| Lakshman, Vir (KMPG 2017 Partner + Head of Chemicals + Pharma in Germany) |
consulting (economic) |
KPMG (Group) |
Germany |
| Lam, Shim Yok (Eppendorf 201107 Managing Director Eppendorf South & Southeast Asia) |
Managing Director |
Eppendorf (Group) |
Malaysia |
| Lambert, Nicole (Messe München 201404 Trade Fair Marketing Manager) |
Sales Manager / Marketing Manager |
Messe München GmbH |
Germany |
| Lambert, Philip (Centogene 202002– CSO located in Cambrigde MA before Life Biosciences + Charles River + VivoPath) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Centogene (Group) |
Germany |
| Lamkemeyer, Tobias (Univ Cologne 201001 Head Proteomics Core Lab) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Cologne (Universität zu Köln) |
Germany |
| Lammers, Paul (Triumvira Immunologics 202008 CEO) |
Chief Executive Officer (CEO) |
Triumvira Immunologics (Group) |
United States (USA) |
| Lammertz, Marion (Ayoxxa Biosystems 201504 Marketing Manager Communications) |
Sales Manager / Marketing Manager |
Ayoxxa (Group) |
Germany |
| Lamotte, André (HBM BioVentures 200505) |
n. a. |
HBM (Group) |
Switzerland |
| Lamottke, Kai (Bicoll 201308 Managing Director) |
Managing Director |
Bicoll (Group) |
Germany |
| Lampert, Mark (Biotechnology Value Fund 201009 Founder) |
Investment Manager |
BVF Partners L.P. (Biotechnology Venture Fund) |
United States (USA) |
| Lampeter, Eberhard F. (Vita 34 1997–201205 Chairman of Management Board RESIGNED 6/12) |
Chief Executive Officer (CEO) |
Vita 34 (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 35 36 37 ... 73 74 75 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
